Study guide
Hyperglycemia, DKA, and HHS
CDCES Certified Diabetes Care and Education Specialist
Track your progress as you read
Finished sections get a check mark.
1 Introduction & the CDCES Exam
About the CDCES Credential & Current Exam Facts The July 2024 Exam Content Outline & Domain Weights The ADCES7 Self-Care Behaviors Framework
2 Pathophysiology, Classification & Diagnosis
Normal Glucose Regulation and the Pathophysiology of T1DM and T2DM Classification and Diagnostic Criteria Risk Factors and Primary Prevention Treatment Goals and Glycemic Targets
3 Assessment: History, Physical & Data
Health History & Diabetes-Specific Physical Assessment Interpreting Diabetes Measures & Laboratory Data Social Determinants of Health & Psychosocial Wellbeing
4 Assessing Self-Management & Learning
Assessing Self-Management Behaviors & Knowledge Assessing Technology Use, Problem-Solving & Risk-Reduction Behaviors Assessing Learning: Goals, Readiness to Change & Literacy Learning Considerations & Barriers
5 Developing the Education & Care Plan
Developing the Individualized Education/Care Plan Instructional Methods & Person-Centered Teaching Strategies SMART Goals, Behavior-Change Theory & Motivational Interviewing
6 Nutrition Therapy
Nutrition Recommendations & Eating Patterns Carbohydrate Counting & Insulin-Food Timing Fats, Protein, Alcohol & Dietary Supplements Food Labels, Weight Management & Special Nutrition Considerations
7 Physical Activity
Physical Activity Recommendations, Benefits, Challenges & Safety Activity Planning with FITT and Adjusting for Planned & Unplanned Activity
8 Pharmacologic Therapy
Insulin — Types, Pharmacokinetics & Delivery Systems Non-Insulin Glucose-Lowering Agents Guideline-Based Medication Selection Medication Titration & Immunizations for People with Diabetes
9 Monitoring
Glucose Monitoring: SMBG, CGM & Time in Range A1C and Ketone Monitoring Cardiometabolic and Organ System Monitoring
10 Acute Complications
Hypoglycemia Hyperglycemia, DKA, and HHS
11 Chronic Complications
Screening Schedules and Microvascular Disease Macrovascular Disease and Lower-Extremity Foot Care Infections, Dental Disease, Sexual Dysfunction, and Other Comorbidities
12 Special Situations & Populations
Sick-Day Management, Surgery, Travel & Emergency Preparedness Special Populations Across the Lifespan Preconception, Pregnancy, Postpartum & Gestational Diabetes Daily Living, Psychosocial Wellbeing & Safety
13 Evaluation & Documentation
Evaluating Intervention Effectiveness & Outcomes Documentation, Plan Revision & Referral
14 Standards, Guidelines & Professional Practice
National Standards for DSMES and the National DPP Applying Evidence-Based Practice Guidelines Population Health, Health Equity & Advocacy
Hyperglycemia, DKA, and HHS
Key Takeaways Explain This Topic AI
DKA is diagnosed with hyperglycemia (glucose >=200 mg/dL or known diabetes), ketosis (beta-hydroxybutyrate >=3.0 mmol/L), and metabolic acidosis (pH <7.3 or bicarbonate <18 mEq/L).
HHS is diagnosed with glucose usually >600 mg/dL, elevated serum osmolality (effective >300 or total >320 mOsm/kg), minimal ketosis, and pH >=7.3.
Euglycemic DKA, linked to SGLT2 inhibitor use, can occur with blood glucose below 200 mg/dL, so ketone testing -- not glucose alone -- confirms the diagnosis.
DKA occurs more often in type 1 diabetes and younger people, while HHS occurs more often in type 2 diabetes and older adults, with higher mortality.
Sick-day rules direct people with diabetes to never stop basal/background insulin, check glucose and ketones frequently during illness, and stay hydrated.
Last updated: July 2026
Hyperglycemia
Hyperglycemia is elevated blood glucose above an individual's target range. It arises from insufficient insulin action relative to glucose load — from missed medication doses, illness, stress hormones, corticosteroid use, or excess carbohydrate intake. As glucose rises, it exceeds the kidney's reabsorption threshold and spills into the urine, pulling water with it through osmotic diuresis; this drives the classic symptoms of polyuria, polydipsia, and dehydration, alongside blurred vision, fatigue, headache, and slow wound healing. Marked hyperglycemia — generally above roughly 250 mg/dL, especially in someone with type 1 diabetes or on insulin — warrants ketone testing because it can signal the start of a hyperglycemic crisis. Left uncorrected, hyperglycemia can progress to one of two life-threatening emergencies: diabetic ketoacidosis (DKA) and the hyperglycemic hyperosmolar state (HHS) .
DKA vs. HHS: Diagnostic Criteria
Criterion DKA HHS
Blood glucose Usually >250 mg/dL (current consensus criteria use ≥200 mg/dL, or any level with known diabetes, to also capture euglycemic DKA) Usually >600 mg/dL
- pH <7.3 ≥7.3 (absence of acidosis)
- Bicarbonate <18 mEq/L ≥15 mEq/L (near-normal)
Ketones Positive — beta-hydroxybutyrate ≥3.0 mmol/L; an elevated anion gap (>12 mmol/L) traditionally supports the diagnosis Minimal to absent — beta-hydroxybutyrate <3.0 mmol/L
- Serum osmolality Variable Elevated — effective osmolality >300 mOsm/kg or total >320 mOsm/kg
- Onset Rapid, over hours Gradual, over days
Typically seen in Type 1 diabetes (also type 2 during severe illness/stress) Type 2 diabetes, especially older adults
Point-of-care blood beta-hydroxybutyrate testing is now the preferred way to diagnose and monitor DKA; anion gap is a supportive but no longer first-line criterion. Clinically, DKA classically presents with rapid, deep Kussmaul breathing, fruity (acetone) breath odor, nausea, vomiting, and abdominal pain, while HHS presents more gradually with profound dehydration and neurologic changes — lethargy, confusion, focal deficits, or seizures — driven by extreme hyperosmolarity. Clinical overlap between DKA and HHS occurs in up to one-third of hyperglycemic crises, and HHS carries a higher mortality rate than DKA because of the degree of dehydration and the comorbidities common in the older adults it typically affects.
Emergency Treatment Overview
Both DKA and HHS are medical emergencies typically managed in an emergency department or intensive care setting, built on three coordinated pillars: IV fluid resuscitation to correct the profound dehydration driven by osmotic diuresis (more severe in HHS), IV insulin therapy to shut off ketone production and gradually lower glucose, and electrolyte monitoring and repletion , especially potassium — insulin drives potassium into cells, so serum potassium can fall sharply during treatment even if it started high. Glucose and, in DKA, ketones/anion gap are followed serially until resolution, and any precipitating cause (infection, missed insulin, new medication) is identified and treated. Correcting glucose too quickly, particularly in HHS, risks dangerous shifts in osmolality, so treatment is deliberately gradual and closely monitored.
Euglycemic DKA and SGLT2 Inhibitors
Euglycemic DKA — ketoacidosis with blood glucose below 200 mg/dL — occurs in roughly 10% of DKA presentations and is increasingly common with SGLT2 inhibitor use, in both type 1 diabetes (off-label) and type 2 diabetes, because these medications lower glucose independent of insulin (via urinary glucose excretion) and can mask the usual glucose warning sign. Anyone taking an SGLT2 inhibitor needs ketone testing whenever they feel unwell, even with a normal-looking glucose reading, because relying on glucose alone can delay recognition of a true emergency.
Precipitating Factors
DKA is most often precipitated by infection or illness, missed or inadequate insulin doses (including pump or infusion-site failure), new-onset type 1 diabetes, myocardial infarction or stroke, and SGLT2 inhibitor use during illness, fasting, surgery, or a very-low-carbohydrate diet. HHS is most often precipitated by infection (the leading cause), medication nonadherence, new-onset type 2 diabetes, and dehydration, along with medications such as glucocorticoids, diuretics, and antipsychotics; older adults with limited access to water, impaired thirst sensation, or cognitive impairment are at particular risk because reduced fluid intake allows hyperosmolarity to progress unchecked.
Sick-Day Rules and Prevention
Never stop basal/background insulin , even when not eating — illness raises counter-regulatory hormones, so insulin needs typically increase, not decrease
Check blood glucose every 2-4 hours during illness
Check ketones (blood or urine) whenever glucose exceeds about 250 mg/dL, during illness, or with nausea/vomiting, especially for type 1 diabetes or insulin pump users
Take supplemental rapid-acting insulin correction doses as directed by the individualized sick-day plan
Stay hydrated with sugar-free fluids; if unable to eat normally, replace carbohydrate with small sips of juice or regular soda
Avoid strenuous exercise when ketones are present, since exercising in this state can worsen ketosis rather than lower glucose
Hold SGLT2 inhibitors during acute illness, prolonged fasting, or before surgery to reduce euglycemic DKA risk
Keep a written sick-day plan developed with the care team, including emergency contact numbers and ketone-testing supplies
When to Seek Emergency Care
Seek immediate emergency care for persistent vomiting or inability to keep fluids down, moderate-to-large ketones that do not improve with correction doses and fluids, blood glucose that stays high despite repeated correction doses, rapid deep (Kussmaul) breathing or fruity-smelling breath, severe abdominal pain, signs of dehydration, or any confusion, extreme drowsiness, or altered mental status — these signal possible DKA or HHS and require prompt evaluation and treatment rather than continued home management.